Insall, Professor Robert r.insall**[ta]**tson.gla.ac.uk
The actin cytoskeleton in cell movement and invasion: SCAR/W****E, WASH and chemotaxis from Dictyostelium to melanoma.Cancer Research UK Beatson Institute 01/12/2012
Preclinical evaluation of selumetinib and glucocorticoid combination therapy for the treatment of Ras pathway positive, high risk acute lymphoblastic leukaemia Newcastle University 01/08/2014
Ismail, Dr Shehab Structural Biology of Cilia Cancer Research UK Beatson Institute 01/01/2014
Jackson, Professor Alan CRUK & EPSRC Cancer Imaging Centre in Cambridge & Manchester University of Manchester 01/12/2013
Jackson, Dr Andrew Andrew.Jackson**[ta]**.nhs.uk
CRUKD/11/012: ROCOCO: A phase I dose escalation trial of Radiotherapy and Olaparib (a PARP1 inhibitor), in combination for carcinoma of the oesophagus Christie NHS Foundation Trust 01/01/2014
Cellular responses to DNA damage University of Cambridge 01/10/2010
Jacobs, Professor Ian i.jacobs**[ta]**w.edu.au Risk Stratifcation, Early Detection and Diagnosis of Ovarian Cancer University of Manchester 01/09/2011
The above is a list of Cancer Research UK’s active publishable awards as of 30 September 2015.For any further enquiries please contact researcher.comments**[ta]**cer.org.uk.James, Professor Nicholas CRUK/09/021: TUXEDO - Phase I/II feasibility study of cetuximab with or without cisplatin with concurrent radiotherapy in muscle invasive bladder cancer University of Birmingham 01/02/2010
CRUK/06/019: STAMPEDE: Systemic Therapy in Advancing or Metastatic Prostate cancer: Evaluation of Drug Efcacy.A three-stage multi-arm, randomised controlled trial University College London 01/10/2006
Jankowski, Professor Janusz janusz.jankowski**[ta]**w.nhs.uk
CRUK/05/006: ASPECT: Aspirin esomeprazole chemoprevention trial University of Oxford 01/01/2005
Jodrell, Professor Duncan duncan.jodrell**[ta]**k.cam.ac.uk
CRUKD/10/
Preclinical combination studies with AZD2014 (mTORi) and Olaparib (AZD2281) University of Cambridge 01/02/2014
Pharmacology and Drug Development Laboratory Cancer Research UK Cambridge Institute 01/11/2012
Joffe, Professor Johnathan CRUK/07/020: TRISST: A randomised phase III trial of imaging and schedule in Seminoma Testis (MRCTE24) University College London 01/10/2007
Johnson, Professor Peter CRUKE/10/024: REMoDL-B: A Randomised Evaluation of Molecular guided therapy for Diffuse Large B-cell Lymphoma with Bortezomib University of Southampton 01/10/2010
CRUK/07/033: RATHL: A randomised trial to assess Response Adapted Therapy using FDG-PET imaging in patients with advanced Hodgkin Lymphoma.University College London 01/05/2008
Identifcation and targeting of clinically relevant molecular and genetic subtypes in colorectal cancer (Supported by the Bobby Moore Fund for CRUK, from May 2014) Queen's University Belfast 01/08/2012
Jones, Professor E.Yvonne The structural biology of recognition and signalling at the cell surface.University of Oxford 01/10/2014
Jones, Professor Nic nic.jones**[ta]**k.manchester.ac.uk
Cell Regulation Group Cancer Research UK Manchester Institute 01/04/2007
Jones, Dr Philip phj20**[ta]**-cu.cam.ac.uk
Clonal evolution in oesophageal squamous preneoplasia Wellcome Trust Sanger Institute 01/07/2014
The above is a list of Cancer Research
CTU QQR CR-UK Clinical Trials Unit Glasgow Beatson West of Scotland Cancer Centre Glasgow University of Glasgow 01/10/2013
Investment to support purchase of electronic remote data capture (eRDC) system for clinical trials University of Glasgow 01/02/2015
A clinical research fellowship in cancer clinical trials University of Glasgow 01/08/2015
CRUKE/12/032: MAdCaP - Mdm2 inhibition and Abiraterone in Carcinoma of the Prostate - a randomized phase II trial of abiraterone acetate with or without RO
Jorgensen, Dr Claus Claus.Jorgensen**[ta]**k.manchester.ac.uk
Analysis of reciprocal tumour-stroma signalling in pancreatic cancer.University of Manchester 01/08/2011
Judson, Professor Ian CRUK/10/021: CASPS: A phase II study of Cediranib (AZD2171) in Alveolar Soft Part Sarcoma (AZ/NCRN) Institute of Cancer Research 01/10/2010
Kamphorst, Dr Jurre jurre.kamphorst**[ta]**sgow.ac.uk
The effect of tumour microenvironment on the metabolism of pancreatic cancer cells University of Glasgow 01/12/2014
Karran, Dr Peter Mammalian DNA Damage Repair Laboratory The Francis Crick Institute 01/11/2010
Katan, Professor Matilda m.katan**[ta]**.ac.uk
FGFR family and their effectors in cancer University College London 01/10/2013
Cancer Research
CRCTU Clinical
Kelsell, Professor David d.p.kelsell**[ta]**l.ac.uk
iRHOM/ADAM
Key, Professor Timothy tim.key**[ta]**.ox.ac.uk
The epidemiology and aetiology of high risk prostate cancer University of Oxford 01/04/2015
The above is a list of Cancer Research
Cancer Research
Khaled, Dr Walid wtk22**[ta]**.ac.uk
Cellular and Molecular Characterisation of
Khaw, Professor Kay-Tee kk101**[ta]**schl.cam.ac.uk
Lifestyle and biological determinants of cancer: the European Prospective Investigation into Cancer in
Khiroya, Dr Heena Iron homeostasis as a potential modulator of cellular proliferation and prognosis in non small cell lung cancer University of Birmingham 01/08/2015
Kiltie, Dr Anne anne.kiltie**[ta]**ology.ox.ac.uk
The role of DNA repair in the aetiology of bladder cancer and its response to radiotherapy and combined modality treatments Cancer Research UK/ MRC Oxford Institute for Radiation Oncology 01/10/2009
Investigating the potential for synergistic radiosensitisation of bladder cancer by gemcitabine and the PARP inhibitor
Kimata, Dr Yuu yk299**[ta]**.ac.uk
Investigation of the roles for the APC/C in the cell cycle control of the centrosome activity and integrity and its spatiotemporal regulation on the
King, Dr Emma e.king**[ta]**on.ac.uk
CRUK/11/047: COAST (Cisplatin Ototoxicity attenuated by ASpirin Trial): A phase II randomised controlled trial of aspirin in the preventative role of cisplatin induced
Immune response evaluation as a prognostic tool in HPV-positive oropharyngeal cancer University of Southampton 01/01/2014
Koh, Dr Dow-Mu Quantitative diffusion-weighted MR imaging of microcapillary perfusion and tissue diffusivity as biomarkers of response to sunitinib treatment in renal cell carcinoma Institute of Cancer Research 01/09/2010
Kouskoff, Dr Valerie valerie.kouskoff**[ta]**k.manchester.ac.uk
Stem cell & haematopoiesis Cancer Research UK Manchester Institute 01/01/2010
Kouzarides, Professor Tony t.kouzarides**[ta]**don.cam.ac.uk
Function of Chromatin Modifcations and their Role in
Kranc, Professor Kamil kamil.kranc**[ta]**ac.uk
Hypoxia signalling pathways in normal and leukaemic stem cell functions University of Edinburgh 01/03/2013
The above is a list of Cancer Research
CRUK/13/008: A Single Arm Phase II trial of BMN673 for inoperable, advanced endometrial cancer with retrospective PTEN, MSI and MRE11 analysis (Supported by Stand Up To Cancer) University College London 01/11/2014
La Thangue, Professor Nicholas nick.lathangue**[ta]**ology.ox.ac.uk
The Cancer Cell Cycle: Control of pRb and p53 tumour suppressor proteins University of Oxford 01/10/2011
Lacaud, Dr Georges georges.lacaud**[ta]**k.manchester.ac.uk
Stem Cell Biology Cancer Research UK Manchester Institute 01/01/2010
Landau, Dr David CRUK/14/027: SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer: a randomised phase III trial University College London 01/09/2015
Langley, Dr Ruth CRUK/12/033: Add-Aspirin Trial- A phase III doubleblind placebo-controlled randomized trial assessing the addition of aspirin after standard primary therapy in early stage common solid tumours University College London 01/09/2013
CRUK/14/039 Prospective sample collection for translational research within the Add-Aspirin trial University College London 01/07/2015
Larkin, Dr James james.larkin**[ta]**.nhs.uk
CRUKE/11/061: A-PREDICT - A Phase II Study Of Axitinib in Patients with Metastatic Renal Cell Cancer Unsuitable for Nephrectomy Institute of Cancer Research 01/05/2012
CRUK/14/036 PERM: A Randomised Phase II Study Assessing Enhancement of Response to MK3475 by High Dose Palliative Radiotherapy in Patients with Advanced Melanoma Royal Marsden NHS Foundation Trust 01/07/2015
Leach, Professor Martin martin.leach**[ta]**.ac.uk
CRUK Cancer Imaging Centre at ICR.Institute of Cancer Research 01/12/2013
Ledermann, Professor Jonathan j.ledermann**[ta]**.ac.uk
Cancer Research UK and UCL Cancer Trials Centre for clinical research in cancer through the development, conduct and analysis of clinical trials University College London 01/10/2013
CRUK/07/025: ICON6: An international randomised trial of molecular targeted therapy with AZD2171 with Pt-based chemotherapy for patients with ovarian cancer relapsing more than 6 months following completion of frst line Pt-based University College London 01/07/2007
The above is a list of Cancer Research
The role of the Bone Morphogenetic Protein (BMP) pathway in the pathogenesis of inherited and sporadic colorectal cancers University of Oxford 01/01/2014
Leigh, Professor Irene i.m.leigh**[ta]**dee.ac.uk
Non melanoma skin cancer from the laboratory to the clinic: Cancer Research UK Skin Tumour Laboratory University of Dundee 01/10/2011
Lemoine, Professor Nick bci-director**[ta]**l.ac.uk
Genomics & Molecular Pathology of Pancreatic Cancer Queen Mary,
Lester, Dr Jason jason.lester2**[ta]**es.nhs.uk
CRUK/10/005: I-START: ISoToxic Accelerated Radiotherapy for Non-small cell lung cancer.Velindre NHS Trust 01/07/2010
Leung, Professor Hing h.leung**[ta]**tson.gla.ac.uk
Urology Research Group Cancer Research UK Beatson Institute 01/08/2011
Lilley, Professor David d.m.j.lilley**[ta]**dee.ac.uk
The Cancer Research-UK Nucleic Acid Structure Research Group : Nucleic acid structure and interactions with proteins University of Dundee 01/01/2011
Lim, Mr Eric e.lim**[ta]**t.nhs.uk
CRUK/12/030: MARS 2- A study to determine if it is feasible to recruit into a randomised trial comparing extended pleurectomy decortication versus no extended pleurectomy decortication in the multimodality management of patients with malignant pleural mesothelioma Royal Brompton & Harefeld NHS Foundation Trust 01/04/2013
Lim, Dr Sean s.h.lim**[ta]**on.ac.uk
Understanding and boosting T-cell transfer therapy in cancer with immunostimulatory
- 項目對接快訊
-
- 最新信息
- 熱門信息
